FDA Approved: ZESTORETIC — Supplemental Application (Almatica Pharma Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ZESTORETIC, the fixed-dose combination of lisinopril and hydrochlorothiazide from Almatica Pharma Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• ZESTORETIC (LISINOPRIL AND HYDROCHLOROTHIAZIDE)

Snippet

SUPPL AP for ZESTORETIC (LISINOPRIL AND HYDROCHLOROTHIAZIDE)